Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS (GCC 1261)

University of Maryland Baltimore (UMB) logo

University of Maryland Baltimore (UMB)




Prostate Cancer

Study type


Funder types




Details and patient eligibility


The investigators' goal is to develop a non-selective and non-invasive procedure to identify aggressive tumors and simultaneously identify their exact location in Prostate cancer patients undergoing radical prostatectomy by combining multiparametric MRI and machine learning techniques. The combination of multi-parametric MRI and machine learning (validated using histopathology) can lead to increased sensitivity and specificity of cancer foci in the prostate, and help in isolating aggressive from indolent tumors. This increased sensitivity and specificity may eventually lead to: a) a reduction in the number of patients that undergo unnecessary treatment, and b) enhance current treatment options by enabling the use of focused therapies. The investigators will recruit 15 patients with prostate cancer that are currently scheduled to undergo radical prostatectomy into the study. All patients will obtain an advanced MRI study prior to the radical prostatectomy. MRI scans will include a) high-resolution volumetric images using T1 and T2-weighted imaging, b) vascular images using dynamic contrast enhanced (DCE) imaging, c) biophysical microstructure images using diffusion-weighted imaging, and d) biochemical images using MR spectroscopic imaging. Following radical prostatectomy, a pathologist will grade the prostatectomy specimens based on standard of care (Gleason grading system). Correlations will be generated between the parameters obtained from scans and from clinical assessments.




18+ years old


No Healthy Volunteers

Inclusion criteria

  1. All male patients that have opted for radical prostatectomy
  2. Subjects must be capable of giving informed consent.
  3. Subjects must not be claustrophobic.

Exclusion criteria

  1. Subjects with pacemakers.
  2. Subjects who have metallic ferromagnetic implants or pumps.
  3. All females are excluded from this study.
  4. Subjects with kidney disease of any severity or on hemodialysis.
  5. Subjects with known allergies to gadolinium-based contrast agents.
  6. Subjects incapable of lying on their backs for up to an hour at a time.

Trial contacts and locations



Data sourced from

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems